James Randleman, MD

James Randleman, MD
  • Watch Video
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Ophthalmology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon Yes
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.444.8158
Desk:
216.444.2030
Fax:
216.445.8475
Specialties & Treatments

Treatment & Services

  • Cataract Evaluations
  • Corneal Collagen Cross-Linking
  • LASIK (Laser in situ Keratomileusis)
  • Phacoemulsification
  • Photorefractive Keratectomy (PRK) Eye Surgery
  • Refractive Cataract Surgery
  • Refractive Lens Exchange
  • Refractive Surgery
View all 8 Treatment & Services +

Specialty in Diseases & Conditions

  • Keratoconus
View all 1 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About James Randleman, MD

J. Bradley Randleman, MD, is a Professor of Ophthalmology at the Cole Eye Institute of the Cleveland Clinic Foundation in Cleveland Ohio.  He was previously Professor of Ophthalmology at the Keck School of Medicine of USC and Director of the Cornea & Refractive Surgery Service at the USC Roski Eye Institute in Los Angeles, California and the Hughes Professor of Ophthalmology at Emory University and Director of the Cornea Section at the Emory Eye Center. A widely respected cornea specialist, his areas of expertise include: corneal and intraocular refractive surgical procedures including LASIK and premium laser-assisted cataract and IOL surgery, complicated cataract surgery, and the management of corneal ectatic disorders.  His primary research focuses on identification and management of corneal ectatic diseases including keratoconus and postoperative ectasia after LASIK, and the avoidance, diagnosis, and management of refractive surgical complications.  He was awarded multiple grants, including an R01 from the NIH to evaluate corneal biomechanical analysis using Brillouin Microscopy.

Dr. Randleman received his BA degree from Columbia College at Columbia University in New York City, his M.D. degree from Texas Tech University School of Medicine in Lubbock, Texas, where he was elected to the Alpha Omega Alpha medical honor society in his junior year, followed by his Ophthalmology residency at Emory University in Atlanta, Georgia.  Dr. Randleman joined the Emory faculty and served as Assistant Residency Director for two years while also completing a fellowship in Cornea/External Disease, and Refractive Surgery at Emory University.  He served as Director of the Emory Corneal Fellowship program until taking over as Director of the Cornea Service in 2010 and was named the Hughes Professor of Ophthalmology in 2016.

Dr. Randleman has been awarded the Claus Dohlman Fellow Award, the inaugural Binkhorst Young Ophthalmologist Award from the American Society of Cataract and Refractive Surgery, the Kritzinger Memorial Award, Founder’s Award, and the Inaugural Recognition Award from the International Society of Refractive Surgery, and the Secretariat Award, Achievement Award, and Senior Achievement Award from the American Academy of Ophthalmology.

Dr. Randleman has served as Editor-in-Chief for the Journal of Refractive Surgery since 2011.  He has authored more than 150 peer-reviewed publications in leading ophthalmology journals in addition to 40 book chapters on refractive surgery evaluation, corneal cross-linking, and management of complications with IOLs, and has authored four textbooks, Collagen Cross-Linking and Corneal Cross-Linking 2nd Edition, which he co-edited on Farhad Hafezi, MD, PhD, Refractive Surgery: An Interactive Case-Based Approach, and Intraocular Lens Surgery: Selection, Complications, and Complex Cases


Education & Professional Highlights

Education & Professional Highlights

Appointed
2019

Education & Fellowships

Fellowship - Emory Eye Clinic
Cornea External Disease and Refractive Surgery
Atlanta, GA USA
2004

Residency - Emory Eye Clinic
Ophthalmology
Atlanta, GA USA
2002

Internship - Atlanta Medical Center
Transitional Year Internship
Atlanta, GA USA
1999

Medical Education - Texas Tech University School of Medicine
Lubbock, TX USA
1998

Graduate School - Sam Houston State University
Graduate Studies in Biology
Huntsville, TX USA
1994

Undergraduate - Columbia University
New York, NY USA
1992

Awards & Honors


  • 1997 Junior Alpha Omega Alpha Medical Honor Society, Texas Tech SOM

    1998 Merck Pharmaceuticals Quest for Excellence Award, Texas Tech SOM

    2001 Outstanding Teaching Resident Award, Emory University

    2004 Claes Dohlman Fellow Society (Outstanding Corneal Fellow in Nation)

    2007 Secretariat Award, American Academy of Ophthalmology

    2008 Achievement Award, American Academy of Ophthalmology

    2010 Premier Surgeon P250 – inaugural member as leading innovator in premium IOL implant surgery

    2010 Binkhorst Young Ophthalmologist Award, American Society of Cataract and Refractive Surgery

    2011-present  America’s Top Doctors (Ophthalmology), Castle Connolly, Ltd.

    2011 Leading Ophthalmologists in America, named by Becker’s ASC Review

    2011 Kritzinger Memorial Award, International Society of Refractive Surgery

    2014 Senior Achievement Award, American Academy of Ophthalmology

    2015 Recognition Award (Inaugural Award), International Society of Refractive Surgery

    2016 Premier Surgeon 300 – leading innovator in premium refractive surgery, Ocular Surgery News

    2016 Jose Ignacio Barraquer Award. Brazilian Society of Cataract and Refractive Surgery

    2016 Atlanta’s Best Doctors, Atlanta Magazine

    2016 Founder’s Award, International Society of Refractive Surgery

    2017-2018 Top Doctors, Pasadena Magazine

    2018 The Power List, The Ophthalmologist (Top 100 most influential people in the world of ophthalmology)

    2018 Award of Excellence in Resident Education, USC Roski Eye Institute

    2018 Secretariat Award, American Academy of Ophthalmology

    2019 President’s Award, International Society of Refractive Surgery
Research & Publications

Research & Publications

See publications for James Randleman, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/7/2019, Dr. Randleman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring James Randleman, MD

Related Videos Featuring James Randleman, MD

Back to Top